Share-based Payment Arrangement, Expense in USD of Kezar Life Sciences, Inc. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kezar Life Sciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to Q3 2025.
  • Kezar Life Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2025 was $2.14M, a 32.9% decline year-over-year.
  • Kezar Life Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2025 was $10.6M, a 17.6% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $13M, a 28.3% decline from 2023.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.1M, a 29.5% increase from 2022.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14M, a 84.4% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Kezar Life Sciences, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $10.6M $2.14M -$1.05M -32.9% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $11.7M $2.42M -$664K -21.5% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $12.4M $2.78M -$655K -19.1% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $13M $3.31M +$87K +2.7% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-25
Q3 2024 $12.9M $3.19M -$3.45M -52% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-12
Q2 2024 $16.4M $3.09M -$935K -23.3% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-13
Q1 2024 $17.3M $3.43M -$829K -19.4% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $18.1M $3.22M -$597K -15.6% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-25
Q3 2023 $18.7M $6.63M +$2.85M +75.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $15.9M $4.02M +$722K +21.9% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $15.2M $4.26M +$1.16M +37.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $14M $3.82M +$1.96M +106% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-25
Q3 2022 $12M $3.79M +$1.91M +102% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $10.1M $3.3M +$1.36M +70.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $8.77M $3.1M +$1.18M +61% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.6M $1.85M +$573K +44.8% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 $7.02M $1.88M +$607K +47.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $6.42M $1.94M +$718K +58.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $5.7M $1.93M +$755K +64.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $4.94M $1.28M +$273K +27.1% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-14
Q3 2020 $4.67M $1.27M +$181K +16.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $4.49M $1.22M +$210K +20.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $4.28M $1.17M +$272K +30.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 $4.01M $1.01M +$558K +124% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-17
Q3 2019 $3.45M $1.09M +$660K +153% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $2.79M $1.01M +$21K +2.13% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $2.77M $901K +$775K +615% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $1.99M $449K Oct 1, 2018 Dec 31, 2018 10-K 2021-03-11
Q3 2018 $430K +$394K +1094% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $988K +$950K +2500% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $126K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q3 2017 $36K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $38K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09

Kezar Life Sciences, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $13M -$5.13M -28.3% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-25
2023 $18.1M +$4.13M +29.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-25
2022 $14M +$6.41M +84.4% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-25
2021 $7.6M +$2.65M +53.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $4.94M +$936K +23.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 $4.01M +$2.01M +101% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $1.99M +$1.79M +882% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $203K +$75K +58.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $128K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.